SLC2A1 and neoplasm: We show that in vivo, pharmacologic LDH inhibition using GNE-140 leads to decreased glucose uptake, GLUT1, and LDH expression in tumor cells while simultaneously increasing glucose uptake and GLUT1 expression in tumor-infiltrating T cells due to increased glucose availability in the TME.